Mitsubishi UFJ Trust & Banking Corp
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1462160
TOKYO, M0
Position in ALNY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$24,079,724
-$7,492,493 QoQ
Shares Held
72,777
-8.3% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88.80827734036852.ToString("F0")%
Shared 0.ToString("F0")%
None 11.191722659631477.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mitsubishi UFJ Trust & Banking Corp holds $300,915,992 across 16 Biotechnology names. ALNY ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
166,903 | $74,528,864 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,494,475 | $71,689,965 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
50,755 | $39,215,342 | |
| 4 | INCY |
Incyte Corp
|
359,761 | $33,860,704 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
72,777 | $24,079,724 | |
| 6 | MRNA |
Moderna, Inc.
|
340,902 | $17,317,821 | |
| 7 | INSM |
INSMED Inc
|
84,184 | $13,765,767 | |
| 8 | EXEL |
Exelixis, Inc.
|
250,407 | $10,739,956 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,079,724 | 72,777 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $31,572,217 | 79,397 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $35,322,216 | 77,461 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $27,957,000 | 85,734 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $29,881,763 | 110,665 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $27,457,382 | 116,686 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $33,094,909 | 120,332 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $65,230,920 | 268,440 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $46,606,280 | 311,852 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $66,825,058 | 349,120 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $68,479,611 | 386,672 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $74,730,183 | 393,441 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $81,717,337 | 407,934 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $109,360,587 | 460,175 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $95,005,543 | 474,648 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $69,143,983 | 474,076 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $76,493,525 | 468,452 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $79,874,043 | 471,011 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $91,921,770 | 486,848 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $84,533,180 | 498,662 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $73,714,025 | 522,091 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $70,553,172 | 542,842 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $80,567,613 | 553,349 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $84,365,528 | 569,614 | Shares | Sole | 2020-09-11 | |
| 2020-03-31 | $62,961,670 | 578,426 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||